Related Experiment Video
Updated: Apr 16, 2026

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
636
Recent progress in the identification and development of anti-malarial agents using virtual screening based
Priyanka Shah, Sunita Tiwari, Mohammad Imran Siddiqi1
1Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow, India. mi_siddiqi@cdri.res.in.
Combinatorial Chemistry & High Throughput Screening
|March 10, 2015
Summary
Developing new malaria drugs is crucial due to parasite resistance. Computer-aided drug design, specifically virtual screening, offers a promising, cost-effective approach for identifying novel anti-malarial compounds.
Area of Science:
- Drug Discovery and Development
- Computational Chemistry
- Parasitology
Background:
- Malaria remains a significant global health challenge, characterized by devastating impacts and rapidly developing drug resistance.
- Current frontline treatments like Artemisinin-based combination therapy (ACT) face emerging parasite resistance, necessitating urgent development of new anti-malarial drugs.
- Computer-aided drug design (CADD) approaches are gaining prominence for identifying and designing novel therapeutic agents.
Purpose of the Study:
- To review recent advancements in identifying and developing anti-malarial compounds using virtual screening.
- To highlight the successful application of in silico methods in anti-malarial drug discovery.
- To encourage integrated, systematic collaborations between experimentalists and computational chemists for efficient drug development.
Main Methods:
- Virtual screening approaches for identifying potential anti-malarial compounds.
- In silico studies for drug design and development.
- Review of recently published research in the field.
Main Results:
- Demonstration of the successful application of in silico studies in anti-malarial drug discovery.
- Identification of virtual screening as a key strategy for novel anti-malarial compound discovery.
- Highlighting the potential for cost and time efficiency in drug development.
Conclusions:
- Virtual screening is a valuable tool for discovering new anti-malarial drugs.
- Integrated computational and experimental approaches can accelerate the development of affordable anti-malarial therapies.
- Further research and collaboration are essential for overcoming drug resistance and combating malaria effectively.
Related Concept Videos
Drug Discovery: Overview
13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
Anthelminthic Agents
90
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
90

